G1 Therapeutics, Inc. (27) | Uncategorized (9)
Recent Contracts
-
Description of Securities of the Registrant
(Filed With SEC on February 23, 2022)
-
Scientific, Clinical, and Regulatory Advisor Agreement by and between the Registrant and Seth A. Rudnick, MD, effective July 1, 2021
(Filed With SEC on August 4, 2021)
-
Description of Securities of the Registrant
(Filed With SEC on February 24, 2021)
-
Senior Advisor Agreement between Registrant and John E. Bailey, Jr. dated September 29, 2020
(Filed With SEC on November 4, 2020)
-
Senior Advisor Agreement between Registrant and Mark A. Velleca, M.D., Ph.D. dated September 29, 2020
(Filed With SEC on November 4, 2020)
-
Scientific, Clinical, and Regulatory Advisor Agreement, by and between the Registrant and Seth A. Rudnick, M.D., effective July 1, 2020
(Filed With SEC on August 5, 2020)
-
Co-Promotion Agreement by and between the Registrant and Boehringer Ingelheim Pharmaceuticals, Inc., dated June 29, 2020
(Filed With SEC on August 5, 2020)
-
Inducement Grant Option Agreement by and between the Registrant and Soma Gupta dated March 31, 2020
(Filed With SEC on May 6, 2020)
-
Description of Securities of the Registrant
(Filed With SEC on February 26, 2020)